Metabolite, immunocyte phenotype, and lymphoma: a Mendelian randomization study DOI Creative Commons

Chenyang Fan,

Pengying Yuan,

Xiangdong Yang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Sept. 25, 2024

Recent studies have confirmed that metabolites and immunocyte phenotype may be associated with the risk of lymphoma. However, bidirectional causality between metabolites, phenotype, disease risk, whether immunity is an intermediate mediator metabolism lymphoma still unclear.

Language: Английский

Current advances in cancer energy metabolism under dietary restriction: a mini review DOI

Liuxin Yang,

Yudian Shao,

Tingting Gao

et al.

Medical Oncology, Journal Year: 2024, Volume and Issue: 41(9)

Published: July 26, 2024

Language: Английский

Citations

1

Cancer metabolic reprogramming and precision medicine-current perspective DOI Creative Commons
Tingting Gao,

Liuxin Yang,

Yali Zhang

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Oct. 17, 2024

Despite the advanced technologies and global attention on cancer treatment strategies, continues to claim lives adversely affects socio-economic development. Although combination therapies were anticipated eradicate this disease, resilient restorative nature of cancers allows them proliferate at expense host immune cells energetically. This proliferation is driven by metabolic profiles specific type patient. An emerging field exploring reprogramming (MR) predict effective treatments. mini-review discusses recent advancements in MR that have contributed predictive, preventive, precision medicine. Current perspectives mechanisms various types prospects for personalized medicine are essential optimizing outputs necessary

Language: Английский

Citations

1

Metabolite, immunocyte phenotype, and lymphoma: a Mendelian randomization study DOI Creative Commons

Chenyang Fan,

Pengying Yuan,

Xiangdong Yang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Sept. 25, 2024

Recent studies have confirmed that metabolites and immunocyte phenotype may be associated with the risk of lymphoma. However, bidirectional causality between metabolites, phenotype, disease risk, whether immunity is an intermediate mediator metabolism lymphoma still unclear.

Language: Английский

Citations

0